SCHEMBL14934677

SCHEMBL14934677

O=C(CCN1C(=O)CCC1=O)NCCO

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
HPGD P15428 2/20 0.52
ALDH1A1 P00352 6/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 3/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.37
LMNA P02545 1/20 0.36
ALPL P05186 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12855219 0.90 HTT (0.54) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL14930710 0.84 SMN1; SMN2 (0.51) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL13268072 0.84 SMN1; SMN2 (0.55) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL29229819 0.84 SMN1; SMN2 (0.51) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL18471568 0.84 SMN1; SMN2 (0.51) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL15150384 0.83 SMN1; SMN2 (0.54) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL16330014 0.83 SMN1; SMN2 (0.54) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL2223882 0.81 SMN1; SMN2 (0.49) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL12713662 0.81 SMN1; SMN2 (0.52) HTTSMN1; SMN2HPGDALDH1A1MEN1
SCHEMBL19401301 0.81 HPGD (0.56) HTTSMN1; SMN2HPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300035-B1 GIP-BASED MIXED AGONISTS FOR TREATMENT OF METABOLIC DISORDERS AND OBESITY UNIV INDIANA RES & TECH CORP (US) 2015-08-12 EP disclosed
WO-2013064508-A1 POLYETHYLENE GLYCOL BASED PRODRUG OF ADRENOMEDULLIN AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-05-10 WO disclosed